Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Andrew Young, MD, PhD, of Pairidex and WashU, and Allyson Mayer, PhD, of Pairidex and BioGenerator Ventures.

Pairidex is the developer of a droplet digital PCR assay designed to enable accurate detection of gene fusions in blood cancer.

Innovators Hour, hosted by BioGenerator, the start-up arm of BioSTL, spotlights the people and ideas shaping St. Louis’ bioscience innovation ecosystem. Watch to discover groundbreaking startups, inspiring stories, and the future of bioscience in our region.

Want more BioSTL?

Website: biostl.org Newsletter: biostl.org/contact/contact-info-and-form

LinkedIn: linkedin.com/company/biostl

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Geneoscopy co-founders Erica Barnell, MD, PhD, and Andrew Barnell, MBA.

Geneoscopy has developed a novel method to reliably extract and quantify eukaryotic RNA biomarkers in stool samples (seRNA). These seRNA biomarkers are being used to develop multiple assays that improve the ability to noninvasively evaluate gastrointestinal disease responses to eradicate cancer.

Innovators Hour, hosted by BioGenerator, the start-up arm of BioSTL, spotlights the people and ideas shaping St. Louis’ bioscience innovation ecosystem. Watch to discover groundbreaking startups, inspiring stories, and the future of bioscience in our region.

Want more BioSTL?

Website: biostl.org

Newsletter: biostl.org/contact/contact-info-and-form

LinkedIn: linkedin.com/company/biostl

Facebook: facebook.com/BioSTL/

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with entrepreneur and professor of biomedical engineering and chemistry, Dr. Cory Berkland of Bond Biosciences and WashU.

Bond Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease.

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with with AgTech innovators Dr. Jeffrey Staub and Tania Seger of Plastomics.

Plastomics, is developing a novel trait delivery technology that places beneficial traits in the chloroplast of plant cells, rather than the nucleus, that enhance crop yields, resistance, and efficiency.

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Dr. Eric C. Leuthardt of WashU Medicine and Aurenar.

Aurenar, founded by Dr. Leuthardt, is creating a unique, disposable wearable neuromodulation device to change the arc of care for ICU patients by reducing life-threatening and costly complications caused by inflammation.

Jim McCarter, Senior Managing Director of BioGeneratorVentures, sits down with Drs. David Holtzman and Randall Bateman of WashU Medicine and C2N Diagnostics.

C2N Diagnostics, founded by Drs. Holtzman and Bateman, isadvancing brain health through cutting-edge diagnostics that support early detection and treatment of neurodegenerative diseases. Their flagship Precivity™ tests use proprietary mass spectrometry and biomarker technology to measure key indicators of Alzheimer’s disease with high accuracy, even before symptoms appear.

Jim McCarter, Senior Managing Director of BioGeneratorVentures, sits down with Edward Weinstein, Co-Founder and CEO of Panome Bio, and Dave Smoller, Co-Founder and Board Member of Panome Bio.

Panome Bio provides next-generation metabolomics andproteomics services to biomedical researchers supporting breakthroughs in drug discovery and human health. Unlike traditional mass spec pipelines that can identify only 5,000 metabolites, Panome Bio utilizes a proprietary approach toidentify all 175,000 unique molecules in the known metabolome.

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Steven Hanley, Chief Executive Officer and Co-Founder of MediBeacon, a clinical-stage U.S. medical diagnostics company pioneering the use of optical agents and transdermal measurement technology to assess organ function in real time.